P012 Ozanimod Reduced Fecal Calprotectin Levels in Patients with Ulcerative Colitis in the Phase 3 True North Study
Am J Gastroenterol
.
2020 Dec 1;115(Suppl 1):S3.
doi: 10.14309/01.ajg.0000722844.18503.37.
Authors
Ghosh Subrata
1
,
D'Haens Geert
2
,
Jairath Vipul
3
,
Rieder Florian
4
,
Petersen AnnKatrin
5
,
Usiskin Keith
5
,
Chitkara Denesh
5
,
Colombel Jean-Frederic
6
Affiliations
1
University of Calgary, Calgary, Canada.
2
Inflammatory Bowel Disease Center, Amsterdam University Medical Center, Amsterdam, Netherlands.
3
Western University, London, Canada.
4
Cleveland Clinic, Cleveland, United States.
5
Bristol-Myers Squibb Company, Princeton, United States.
6
Mount Sinai Medical Center, New York, United States.
PMID:
33566486
DOI:
10.14309/01.ajg.0000722844.18503.37
No abstract available